156 related articles for article (PubMed ID: 36693543)
1. Botulinum Toxin Versus Dextrose Prolotherapy: Which is More Effective for Temporomandibular Joint Subluxation? A Randomized Clinical Trial.
Cömert Kiliç S; Kiliç N; Güngörmüş M
J Oral Maxillofac Surg; 2023 Apr; 81(4):389-395. PubMed ID: 36693543
[TBL] [Abstract][Full Text] [Related]
2. Is dextrose prolotherapy superior to placebo for the treatment of temporomandibular joint hypermobility? A randomized clinical trial.
Cömert Kiliç S; Güngörmüş M
Int J Oral Maxillofac Surg; 2016 Jul; 45(7):813-9. PubMed ID: 26846795
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Efficacy of Different Concentrations of Dextrose Prolotherapy in Temporomandibular Joint Hypermobility Treatment.
Mustafa R; Güngörmüş M; Mollaoğlu N
J Craniofac Surg; 2018 Jul; 29(5):e461-e465. PubMed ID: 29533255
[TBL] [Abstract][Full Text] [Related]
4. Long-term therapeutic effects of dextrose prolotherapy in patients with hypermobility of the temporomandibular joint: a single-arm study with 1-4 years' follow up.
Refai H
Br J Oral Maxillofac Surg; 2017 Jun; 55(5):465-470. PubMed ID: 28460873
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: a preliminary prospective, randomized, double-blind, placebo-controlled clinical trial.
Refai H; Altahhan O; Elsharkawy R
J Oral Maxillofac Surg; 2011 Dec; 69(12):2962-70. PubMed ID: 21757278
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of prolotherapy and arthrocentesis in management of temporomandibular joint hypermobility.
Taşkesen F; Cezairli B
Cranio; 2023 Sep; 41(5):423-431. PubMed ID: 33326351
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of dextrose prolotherapy over placebo for temporomandibular joint hypermobility: A systematic review and meta-analysis.
Nagori SA; Jose A; Gopalakrishnan V; Roy ID; Chattopadhyay PK; Roychoudhury A
J Oral Rehabil; 2018 Dec; 45(12):998-1006. PubMed ID: 30024045
[TBL] [Abstract][Full Text] [Related]
8. Results of Combined, Single-Session Arthrocentesis and Dextrose Prolotherapy for Symptomatic Temporomandibular Joint Syndrome: A Case Series.
Cezairli B; Sivrikaya EC; Omezli MM; Ayranci F; Seyhan Cezairli N
J Altern Complement Med; 2017 Oct; 23(10):771-777. PubMed ID: 29017019
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy of autologous conditioned serum versus dextrose prolotherapy in internal derangement of the TMJ - A pilot study.
Ravikumar C; Sasikala B; Krishnakumar Raja VB; Elavenil P
J Craniomaxillofac Surg; 2024 Apr; 52(4):477-483. PubMed ID: 38368212
[TBL] [Abstract][Full Text] [Related]
10. Dextrose Prolotherapy Versus Lidocaine Injection for Temporomandibular Dysfunction: A Pragmatic Randomized Controlled Trial.
Zarate MA; Frusso RD; Reeves KD; Cheng AL; Rabago D
J Altern Complement Med; 2020 Nov; 26(11):1064-1073. PubMed ID: 32780636
[No Abstract] [Full Text] [Related]
11. Short-term results of prolotherapy in the management of temporomandibular joint dislocation.
Ungor C; Atasoy KT; Taskesen F; Cezairli B; Dayisoylu EH; Tosun E; Senel FC
J Craniofac Surg; 2013 Mar; 24(2):411-5. PubMed ID: 23524704
[TBL] [Abstract][Full Text] [Related]
12. Dextrose prolotherapy for pain and dysfunction of the TMJ reducible disc displacement: A randomized, double-blind clinical study.
Haggag MA; Al-Belasy FA; Said Ahmed WM
J Craniomaxillofac Surg; 2022 May; 50(5):426-431. PubMed ID: 35501215
[TBL] [Abstract][Full Text] [Related]
13. The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study.
Rezazadeh F; Esnaashari N; Azad A; Emad S
BMC Oral Health; 2022 May; 22(1):217. PubMed ID: 35641993
[TBL] [Abstract][Full Text] [Related]
14. Application of auriculotemporal nerve block and dextrose prolotherapy in exercise therapy of TMJ closed lock in adolescents and young adults.
Zhou H; Xue Y; Liu P
Head Face Med; 2021 Mar; 17(1):11. PubMed ID: 33773589
[TBL] [Abstract][Full Text] [Related]
15. Does Adjunctive Botulinum Toxin A Reduce Pain Scores When Combined With Temporomandibular Joint Arthroscopy for the Treatment of Concomitant Temporomandibular Joint Arthralgia and Myofascial Pain?
Thomas NJ; Aronovich S
J Oral Maxillofac Surg; 2017 Dec; 75(12):2521-2528. PubMed ID: 28500876
[TBL] [Abstract][Full Text] [Related]
16. Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation.
Zhou H; Hu K; Ding Y
Br J Oral Maxillofac Surg; 2014 Jan; 52(1):63-6. PubMed ID: 24064304
[TBL] [Abstract][Full Text] [Related]
17. Comparison of autologous blood prolotherapy and 25% dextrose prolotherapy for the treatment of chronic recurrent temporomandibular joint dislocation on the basis of clinical parameters: A retrospective study.
Pandey SK; Baidya M; Srivastava A; Garg H
Natl J Maxillofac Surg; 2022; 13(3):398-404. PubMed ID: 36683930
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-guided lateral pterygoid muscle botulinum toxin: an injection for recurrent temporomandibular joint dislocation in a brain injury patient.
Guo HJ; Wu CC; Li TC
Oral Maxillofac Surg; 2023 Jun; 27(2):365-371. PubMed ID: 35486190
[TBL] [Abstract][Full Text] [Related]
19. Effect of multiple injections of botulinum toxin into painful masticatory muscles on bone density in the temporomandibular complex.
Raphael KG; Janal MN; Tadinada A; Santiago V; Sirois DA; Lurie AG
J Oral Rehabil; 2020 Nov; 47(11):1319-1329. PubMed ID: 32885475
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection (Prolotherapy): A Randomized Controlled Trial With Long-term Partial Crossover.
Louw WF; Reeves KD; Lam SKH; Cheng AL; Rabago D
Mayo Clin Proc; 2019 May; 94(5):820-832. PubMed ID: 30878157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
